Undiagnosed diabetes in kidney transplant candidates: A case-finding strategy

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 4, 2010, Pages 616-622

  Bergrem, Henrik Andreas ^a   Valderhaug, Tone Gretland ^a   Hartmann, Anders ^a   Hjelmesaeth, Jøran ^a   Leivestad, Torbjørn ^b   Bergrem, Harald ^c   Jenssen, Trond ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b VESTFOLD HOSPITAL TRUST   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CASE FINDING; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATIENT REFERRAL; PERITONEAL DIALYSIS; PREOPERATIVE EVALUATION; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NORWAY; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 77950925929     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07501009     Document Type: Article

References (37)

1. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde O, Goto N: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7: 1506-1514, 2007 (Pubitemid 46776239)
2. Lin-Tan DT, Lin JL, Wang LH, Wang LM, Huang LM, Liu L, Huang JY, Huang YL: Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. JAmSoc Nephrol 18: 2385-2391, 2007 (Pubitemid 47203854)
3. Mathew JT, Rao M, Job V, Ratnaswamy S, Jacob CK: Post-transplant hyperglycaemia: A study of risk factors. Nephrol Dial Transplant 18: 164-171, 2003 (Pubitemid 36104494)
4. Nam JH, Mun JI, Kim SI, Kang SW, Choi KH, Park K, Ahn CW, Cha BS, Song YD, Lim SK, Kim KR, Lee HC, Huh KB: Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 71: 1417-1423, 2001 (Pubitemid 32507115)
5. Ramesh Prasad GV, Huang M, Bandukwala F, Nash MM, Rapi L, Montada-Atin T, Meliton G, Zaltzman JS: Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation. Clin Nephrol 71: 140-146, 2009
6. Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, Nakao A: Diabetes mellitus after transplant: Relationship to pre-transplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 76:1320-1326, 2003 (Pubitemid 37430718)
7. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T: The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 69: 588-595, 2006 (Pubitemid 43164454)
8. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178-185, 2003 (Pubitemid 36323115)
9. Lentine KL, Brennan DC, Schnitzler MA: Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 16: 496-506, 2005 (Pubitemid 41725147)
10. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, Uchida K, Valantine H, Villamil F, Vincenti F, Wissing M: Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 19: 291-298, 2005 (Pubitemid 40711959)
11. Armstrong KA, Prins JB, Beller EM, Campbell SB, Hawley CM, Johnson DW, Isbel NM: Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol 1: 100-108, 2006
12. Hoban R, Gielda B, Temkit M, Saha C, Book BK, Baker E, Pescovitz MD: Utility of HbA1c in the detection of subclin-ical post renal transplant diabetes. Transplantation 81: 379-383, 2006 (Pubitemid 43255723)
13. Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth, J: Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 88: 429-434, 2009
14. DECODE Study Group: Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 42: 647-654, 1999
15. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 27[Suppl 1]: S5-S10, 2004
16. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation, Geneva, World Health Organization, 2006
17. Perkins NJ, Schisterman EF: The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 163: 670-675, 2006
18. Jaeschke R, Guyatt G, Sackett DL: Users' guides to the medical literature: III. How to use an article about a diagnostic test: A. Are the results of the study valid? JAMA 271: 389-391, 1994 (Pubitemid 24986679)
19. Horton NJ, Kleinman KP: Much ado about nothing: A comparison of missing data methods and software to fit incomplete data regression models. Am Stat 61: 79-90, 2007
20. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Ken-ward MG, Wood AM, Carpenter JR: Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 338: b2393, 2009
21. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 67: 563-568, 1981 (Pubitemid 11141740)
22. Mak RH: Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial 13: 4-8, 2000
23. Elbert A, Schreier L, Galli C, Beresan H, Lopez G, Traversa M, Berg G: Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria. JRen Nutr 16: 300-303, 2006 (Pubitemid 44548405)
24. Rufino M, Barbero P, Hernandez D, Torres A, Lorenzo V: Importance of oral glucose overload test (OGOT) at a specific clinic for advanced CRF stages IV and V. Nefrologia 27: 30-37, 2007
25. Bennett CM, Guo M, Dharmage SC: HbA(1c) as a screening tool for detection of Type 2 diabetes: A systematic review. Diabet Med 24: 333-343, 2007 (Pubitemid 46452406)
26. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y: Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. J Am Soc Nephrol 18: 896-903, 2007 (Pubitemid 46434506)
27. Joy MS, Cefalu WT, Hogan SL, Nachman PH: Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 39: 297-307, 2002 (Pubitemid 34174252)
28. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48: 436-472, 2002 (Pubitemid 34174577)
29. Smith WG, Holden M, Benton M, Brown CB: Glycosylated and carbamylated haemoglobin in uraemia. Nephrol Dial Transplant 4: 96-100, 1989 (Pubitemid 19077596)
30. Szymezak J, Lavalard E, Martin M, Leroy N, Gillery P: Car-bamylated hemoglobin remains a critical issue in HbA1c measurements. Clin Chem Lab Med 47: 612-613, 2009
31. Bry L, Chen PC, Sacks DB: Effects of hemoglobin variants and chemically modified derivatives on assays for glyco-hemoglobin. Clin Chem 47: 153-163, 2001 (Pubitemid 32142912)
32. Weykamp CW, Miedema K, de Haan T, Doelman CJ: Car-bamylated hemoglobin interference in glycohemoglobin assays. Clin Chem 45: 438-440, 1999 (Pubitemid 29114192)
33. Nathan DM, Balkau B, Bonora E, Borch-Johnsen K, Buse JB, Colagiuri S, Davidson MB, DeFronzo R, Genuth S, Holman RR, Ji L, Kirkman S, Knowler WC, Schatz D, Shaw J, Sobngwi E, Steffes M, Vaccaro O, Wareham N, Zinman B, Kahn R: International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 32: 1327-1334, 2009
34. Barrett-Connor E, Ferrara A: Isolated postchallenge hyper-glycemia and the risk of fatal cardiovascular disease in older women and men: The Rancho Bernardo Study. Diabetes Care 21: 1236-1239, 1998 (Pubitemid 28365676)
35. DECODE Study Group: Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26: 688-696, 2003
36. Selvin E, Crainiceanu CM, Brancati FL, Coresh J: Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 167: 1545-1551, 2007 (Pubitemid 47124186)
37. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodwarth TG, Brennan DC: Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3: 590-598, 2003 (Pubitemid 36612842)